Inter-relations between osteoarthritis and metabolic syndrome: A common link?

• Published in: Biochimie Vol. 121; pp. 238 - 252
• Main Authors: Le Clanche, S., Bonnefont-Rousselot, D., Sari-Ali, E., Rannou, F., Borderie, D.
• Format: Journal Article
• Language: English
• Published: France Elsevier B.V 01.02.2016
• Subjects: Adipokines - metabolism; Chondrocytes - metabolism; Diabetes Mellitus, Type 2 - metabolism; Dyslipidemia; Humans; Hyperglycemia; Hyperglycemia - metabolism; Metabolic syndrome; Metabolic Syndrome - complications; Metabolic Syndrome - metabolism; Mitochondrial dysfunction; Obesity; Osteoarthritis; Osteoarthritis - complications; Osteoarthritis - metabolism; Obesity; Hyperglycemia; Mitochondrial dysfunction; Metabolic syndrome; Osteoarthritis; Dyslipidemia
• ISSN: 0300-9084; 1638-6183
• DOI: 10.1016/j.biochi.2015.12.008

Osteoarthritis (OA) is a degenerative disorder of the joint, principally occurring during aging, and characterized by a focal degradation of cartilage. It is the most prevalent rheumatic disease in industrialized countries and represents the second cause of disability in France. However, the etiology of OA remains unclear. There is only one cell type found in cartilage, chondrocyte, which is responsible for its repair and the synthesis of the elements of the extra-cellular matrix. A dysfunction of these cells results in an imbalance between repair and degradation in cartilage, leading to its destruction. Recently, a link between OA and metabolic syndrome (MetS) has been suggested, introducing a notion of metabolic OA, and a new vision of the disease. MetS is characterized by a cluster of factors (insulin resistance, hypertension, dyslipidemia, visceral obesity), although there is still no clear definition of it. During the 20th century, MetS dramatically increased with changes in population lifestyle, becoming a major health issue in industrialized countries. MetS concerns 10–30% of the worldwide population, but is prevalent in 59% of OA patients. Patients with both OA and MetS have more severe symptoms, occurring sooner than in the general population. Indeed, OA is generally a disease concerning the population over 65 years old, but with an associated MetS the target population is around 50 years old. In this review, we will focus on common factors in OA and MetS, such as hypertension, obesity, dyslipidemia, mitochondrial dysfunction and hyperglycemia, linking one disease to the other. •OA is the most common rheumatic disease in the world.•Adipokines levels are involved in development and progression of MetS as well as OA.•Mitochondrial dysfunctions are involved in OA and MetS development and progression.•Hyperglycemia leads to type 2 diabetes and to chondrocyte dysfunctions.•OA and MetS are linked in many ways implying to consider OA as a metabolic disorder.